Nigeria looks inward for locally made vaccines
Nigeria’s Vice President, Yemi Osinbajo says the African Centre of Excellence for the Genomics of Infectious Disease in Nigeria has developed an efficacious rapid test for coronavirus and is working on a vaccine in collaboration with the UK’s Diosynvax. Elsewhere, Guinea has so far reported 23 cases in the wake of a new Ebola outbreak. Joining CNBC Africa for more is Niniola Williams, Managing Director of Drasa Health Trust.
Tue, 13 Apr 2021 14:16:56 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
AI Generated Summary
- Development of rapid tests and vaccine collaboration showcase Nigeria's commitment to local healthcare solutions
- Community engagement and leadership support are crucial for promoting acceptance of locally made vaccines
- Lessons from Ebola outbreak underscore the importance of preparedness and the need for sustainable vaccine production
Nigeria is taking significant strides in the fight against infectious diseases with the development of efficacious rapid tests for coronavirus and the ongoing collaboration with the UK's Diosynvax to work on a vaccine. The African Centre of Excellence for the Genomics of Infectious Disease in Nigeria has been at the forefront of these efforts, showcasing the potential for locally made vaccines to address health emergencies. Niniola Williams, the Managing Director of Drasa Health Trust, commended these initiatives, highlighting the importance of building sustainable health systems in the wake of the COVID-19 pandemic.
Williams emphasized the need for local production and distribution of vaccines, pointing out that the current level of hesitancy towards foreign vaccines presents an opportunity for domestically made solutions to gain acceptance. She stressed the importance of community engagement and leadership support in driving vaccine uptake, citing research that suggests people may be more inclined to trust locally produced vaccines over foreign ones.
In parallel, the recent Ebola outbreak in Guinea has underscored the importance of preparedness and surveillance in combating infectious diseases. Guinea has received its first set of vaccines to inoculate frontline health workers and high-risk individuals, signaling a proactive approach to containing the outbreak. While the current supply of vaccines is sourced from outside the country, there is growing recognition of the need to enhance local production capabilities to ensure sustainable healthcare interventions.
Across the region, countries like Nigeria are leveraging lessons from the COVID-19 response to bolster their readiness for public health threats. Innovations such as international travel tracking systems are being repurposed to monitor potential risks and enhance surveillance efforts for diseases like Ebola. This cross-pollination of strategies highlights the value of investing in resilient healthcare systems that can adapt to evolving challenges.
As the global health landscape continues to evolve, the emphasis on local production of vaccines and preparedness for infectious disease outbreaks remains paramount. Nigeria's efforts to develop indigenous healthcare solutions serve as a beacon of hope in the quest for sustainable and effective responses to public health crises.